NEW YORK (GenomeWeb News) – Atossa Genetics today said that revenues for 2012 increased sharply following the launch of two tests.

Separately, the company also said that it has entered into a $30 million stock purchase agreement with Aspire Capital.

The Seattle-based company brought in revenues of $481,842 in 2012, compared to $1,500 in 2011. Of that total $475,402 resulted from its diagnostic testing service, while $6,440 derived from sales of Atossa's MASCT Systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.